Drug Profile
Palifermin biosimilar - Nanogen Biopharmaceutical
Alternative Names: Keratinocyte growth factor - NanogenLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Nanogen Biopharmaceutical Co
- Class Chemoprotectants; Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stomatitis
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for research development in Stomatitis in Vietnam (IV, Injection)
- 19 Mar 2014 Early research in Stomatitis in Vietnam (IV)